We do not have a field service, so we are pleased to send you free product samples and information. Through our sample distribution, we want to give you the opportunity to form your own opinion, provide your patients with comprehensive and straightforward advice, and offer them an evidence-based option.
Learn everything about RetiCap®DR – from its ingredients and mechanisms of action to clinical study data. The complex pathogenesis of diabetic retinopathy (DR) is triggered by hyperglycaemia-induced oxidative stress (OS), which damages capillary endothelial cells, nerve cells, and glial cells in the retina. Increased OS leads to changes in cellular metabolism.
The vitreous body has a unique protective mechanism against oxidative stress and collagen glycation. However, this mechanism loses efficacy during degeneration. Providing the eye with naturally occurring micronutrients can help reactivate this mechanism, minimising or even preventing collagen fibres from clumping. Discover all about VitroCap®N, including its ingredients, mechanism of action, clinical study data, and expert panel discussions with eye care professionals who have up to 10 years of experience using the product.
Since 2013, extensive scientific studies have investigated important new findings on the effectiveness of VitroCap®N. In five clinical studies, European researchers observed significant improvements in patients with vitreous opacities through the intake of the micronutrients contained in VitroCap®N.
During the 35th International Congress of the German Ophthalmic Surgery Society, ebiga-VISION invited renowned scientists and ophthalmologists to a satellite symposium dedicated to the vitreous body. The presentations and discussions by doctors and researchers summarized the latest findings on vitreous degeneration, its impact on visual performance and quality of life, as well as both surgical and non-surgical treatment options for everyday clinical practice.
ebiga-Vision is a company specializing in vision science, committed to diagnosing, preventing, and treating eye conditions and chronic diseases affecting vision. Headquartered in Greifswald, the family-owned business aims to equip ophthalmologists and patients, both in Germany and internationally, with cutting-edge tools to help prevent chronic eye disorders. With a focus on research and development, ebiga-Vision also offers nutritional supplements designed to meet the specific micronutrient needs of the eyes. Their current areas of focus include vitreous degeneration, diabetes-related eye issues, macular degeneration, and glaucoma.
In 2025 we will be exhibiting at optometry and ophthalmology conferences in the UK, Ireland, and the USA. Big or small, each of these events is a unique chance to meet dedicated, education-driven eye care professionals. Whether it’s discussing our double-blind, placebo-controlled trials, exploring the mechanisms behind supplementation, or sharing samples with curious and skeptical eyes alike—we cherish every interaction.
Thank you to everyone who stops by to chat, engage, and explore the latest in research and technology with us. We look forward to seeing more of you!
Oxidative stress plays a key role in #glaucoma pathogenesis, contributing to mitochondrial dysfunction, DNA damage, and retinal ganglion cell apoptosis. Current research in this area
…
